← SynDRA
IMILOXAN
SynDRA canonical compound SYN0005258 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | ADRA2B |
| Mechanism of action | Adrenergic receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Adrenergic receptor antagonist
- ADRA2B ANTAGONIST
Cross-references
Synonyms
- RS-21361
- GNF-Pf-2156
- Imiloxan [INN]
- ZJ56PS1DWK
- NCGC00015570-04
- 2-((2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methyl)-1-ethyl-1H-imidazole
- RS 21361;RS-21361;RS21361
- Imiloxanum
- Imiloxano
- Imiloxanum [Latin]
- CAS-81167-16-0
- Imiloxano [Spanish]
- (RS)-2-(1,4-Benzodioxan-2-ylmethyl)-1-ethylimidazol
- UNII-ZJ56PS1DWK
- Lopac0_000703
- SCHEMBL757962
- CHEMBL347695
- GTPL3470
- (+-)-2-(1,4-Benzodioxan-2-ylmethyl)-1-ethylimidazole
- DTXSID1045162
- BDBM85234
- CHEBI:91522
- 2-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)-1-ethylimidazole
- Tox21 110175
- Tox21_110175
- PDSP1_001499
- PDSP2_001483
- 1H-Imidazole, 2-[(2,3-dihydro-1,4-benzodioxin-2-yl)methyl]-1-ethyl-
- Tox21_110175_1
- CCG-204788
- NSC_133621
- SDCCGSBI-0050681.P002
- NCGC00015570-03
- NCGC00015570-05
- NCGC00015570-06
- NCGC00015570-07
- NCGC00024917-02
- NCGC00024917-03
Look up IMILOXAN in the interactive SynDRA portal →